Michael Morse, MD, MHS, FACP is Professor of Medicine, Division of Medical Oncology and Professor in the Department of Surgery. His clinical expertise includes management of gastrointestinal malignancies with an emphasis on cancers involving the liver. His research expertise includes the translational development of targeted therapies and cancer vaccines and other immunotherapies. He has published extensively on topics in cancer immunotherapy, targeted therapies, and gastrointestinal malignancies, including textbooks on cancer vaccines and liver tumors.